126 related articles for article (PubMed ID: 9466344)
1. Inhibition of nifedipine metabolism in dogs by erythromycin: difference between the gut wall and the liver.
Tsuruta S; Nakamura K; Arimori K; Nakano M
J Pharm Pharmacol; 1997 Dec; 49(12):1205-10. PubMed ID: 9466344
[TBL] [Abstract][Full Text] [Related]
2. Effects of erythromycin, clarithromycin and rokitamycin on nifedipine metabolism in rats.
Tsuruta S; Nakamura K; Arimori K; Nakano M
Biol Pharm Bull; 1997 Apr; 20(4):411-6. PubMed ID: 9145220
[TBL] [Abstract][Full Text] [Related]
3. An in-vitro study on the metabolism of rokitamycin and possible interactions of the drug with rat liver microsomes.
Zhao XJ; Ishizaki T
J Pharm Pharmacol; 1999 Oct; 51(10):1167-74. PubMed ID: 10579688
[TBL] [Abstract][Full Text] [Related]
4. Effect of oral ketoconazole on first-pass effect of nifedipine after oral administration in dogs.
Kuroha M; Kayaba H; Kishimoto S; Khalil WF; Shimoda M; Kokue E
J Pharm Sci; 2002 Mar; 91(3):868-73. PubMed ID: 11920771
[TBL] [Abstract][Full Text] [Related]
5. Effects of CYP3A inhibition on the metabolism of cilostazol.
Suri A; Forbes WP; Bramer SL
Clin Pharmacokinet; 1999; 37 Suppl 2():61-8. PubMed ID: 10702888
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and transport of the macrolide immunosuppressant sirolimus in the small intestine.
Lampen A; Zhang Y; Hackbarth I; Benet LZ; Sewing KF; Christians U
J Pharmacol Exp Ther; 1998 Jun; 285(3):1104-12. PubMed ID: 9618413
[TBL] [Abstract][Full Text] [Related]
7. Effect of CYP3A inhibition on vesnarinone metabolism in humans.
Wandel C; Lang CC; Cowart DC; Girard AF; Bramer S; Flockhart DA; Wood AJ
Clin Pharmacol Ther; 1998 May; 63(5):506-11. PubMed ID: 9630823
[TBL] [Abstract][Full Text] [Related]
8. Role of small intestinal cytochromes p450 in the bioavailability of oral nifedipine.
Zhang QY; Kaminsky LS; Dunbar D; Zhang J; Ding X
Drug Metab Dispos; 2007 Sep; 35(9):1617-23. PubMed ID: 17567730
[TBL] [Abstract][Full Text] [Related]
9. Studies on interactions between functional foods or dietary supplements and medicines. I. Effects of Ginkgo biloba leaf extract on the pharmacokinetics of diltiazem in rats.
Ohnishi N; Kusuhara M; Yoshioka M; Kuroda K; Soga A; Nishikawa F; Koishi T; Nakagawa M; Hori S; Matsumoto T; Yamashita M; Ohta S; Takara K; Yokoyama T
Biol Pharm Bull; 2003 Sep; 26(9):1315-20. PubMed ID: 12951478
[TBL] [Abstract][Full Text] [Related]
10. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.
Gorski JC; Jones DR; Haehner-Daniels BD; Hamman MA; O'Mara EM; Hall SD
Clin Pharmacol Ther; 1998 Aug; 64(2):133-43. PubMed ID: 9728893
[TBL] [Abstract][Full Text] [Related]
11. Prediction of midazolam-CYP3A inhibitors interaction in the human liver from in vivo/in vitro absorption, distribution, and metabolism data.
Yamano K; Yamamoto K; Katashima M; Kotaki H; Takedomi S; Matsuo H; Ohtani H; Sawada Y; Iga T
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):443-52. PubMed ID: 11259329
[TBL] [Abstract][Full Text] [Related]
12. Effect of calcium channel antagonists nifedipine and nicardipine on rat cytochrome P-450 2B and 3A forms.
Zangar RC; Okita JR; Kim H; Thomas PE; Anderson A; Edwards RJ; Springer DL; Okita RT
J Pharmacol Exp Ther; 1999 Sep; 290(3):1436-41. PubMed ID: 10454523
[TBL] [Abstract][Full Text] [Related]
13. Effect of Lactobacillus casei on the absorption of nifedipine from rat small intestine.
Kato R; Yuasa H; Inoue K; Iwao T; Tanaka K; Ooi K; Hayashi Y
Drug Metab Pharmacokinet; 2007 Apr; 22(2):96-102. PubMed ID: 17495416
[TBL] [Abstract][Full Text] [Related]
14. The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism.
Holtbecker N; Fromm MF; Kroemer HK; Ohnhaus EE; Heidemann H
Drug Metab Dispos; 1996 Oct; 24(10):1121-3. PubMed ID: 8894514
[TBL] [Abstract][Full Text] [Related]
15. Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A.
Ma B; Prueksaritanont T; Lin JH
Drug Metab Dispos; 2000 Feb; 28(2):125-30. PubMed ID: 10640508
[TBL] [Abstract][Full Text] [Related]
16. Effects of pioglitazone on the pharmacokinetics of nifedipine and its main metabolite, dehydronifedipine, in rats.
Choi JS; Choi I; Choi DH
Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):231-8. PubMed ID: 25549928
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetics of m-nifedipine in Beagle dogs].
Yang ZF; Zhou SY; Yang TH; Mei QB
Yao Xue Xue Bao; 2004 Aug; 39(8):609-12. PubMed ID: 15563062
[TBL] [Abstract][Full Text] [Related]
18. Role of cytochrome P450 3A in the metabolism of mefloquine in human and animal hepatocytes.
Fontaine F; de Sousa G; Burcham PC; Duchêne P; Rahmani R
Life Sci; 2000 Apr; 66(22):2193-212. PubMed ID: 10834303
[TBL] [Abstract][Full Text] [Related]
19. Erythromycin-felodipine interaction: magnitude, mechanism, and comparison with grapefruit juice.
Bailey DG; Bend JR; Arnold JM; Tran LT; Spence JD
Clin Pharmacol Ther; 1996 Jul; 60(1):25-33. PubMed ID: 8689808
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of CYP3A by erythromycin: in vitro-in vivo correlation in rats.
Zhang X; Galinsky RE; Kimura RE; Quinney SK; Jones DR; Hall SD
Drug Metab Dispos; 2010 Jan; 38(1):61-72. PubMed ID: 19797607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
